Drug discovery studies on quinoline-based derivatives as potential antimalarial agents

SAR and QSAR in Environmental Research

Volumn 25, Issue 3, 2014, Pages 189-203

  Sharma, R ^a   Patil, S ^a   Maurya, P ^a  

^a DEVI AHILYA UNIVERSITY   (India)

Author keywords

antimalarial activity; CoMFA; CoMSIA; HQSAR; molecular modelling; quinoline based derivatives

Indexed keywords

BINDING ENERGY; COMPLEXATION; COMPUTATIONAL CHEMISTRY; HYDROGEN BONDS; MOLECULAR GRAPHICS;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL AGENT; COMFA; COMSIA; DRUG DISCOVERY; HQSAR; MOLECULAR MODELING STUDIES; QUINOLINE-BASED DERIVATIVE; STRUCTURAL REQUIREMENTS; TRAINING SETS;

MOLECULAR MODELING;

PLASMODIUM FALCIPARUM;

ANTIMALARIAL AGENT; LACTATE DEHYDROGENASE; QUINOLONE DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECT; ENZYMOLOGY; METABOLISM; METHODOLOGY; MOLECULAR DOCKING; PLASMODIUM FALCIPARUM; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTIMALARIALS; DRUG DISCOVERY; L-LACTATE DEHYDROGENASE; MOLECULAR DOCKING SIMULATION; PLASMODIUM FALCIPARUM; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; QUINOLONES;

EID: 84896319723     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/1062936X.2013.875484     Document Type: Article

References (20)

1. WHO, World Malaria Report (2012), World Health Organization, Geneva, 2012.
2. P. Shah and M.I. Siddiqi, 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors, SAR QSAR Environ. Res. 21 (2010), pp. 527-545.
3. A.K. Gupta and A.K. Saxena, Triple-layered QSAR studies on substituted 1,2,4-trioxanes as potential antimalarial agents: Superiority of the quantitative pharmacophore-based alignment over common substructure based alignment, SAR QSAR Environ. Res. (2012), pp. 1-16.
4. S. Deshpande, S. Jaiswal, S.B. Katti, and Y.S. Prabhakar, CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents, SAR QSAR Environ. Res. 22 (2011), pp. 473-488.
5. C.W. Wright, Traditional antimalarials and the development of novel antimalarial drugs, J. Ethnopharmacol. 100 (2005), pp. 67-71.
6. S. Saxena, S.S. Chaudhaery, K. Varshney, and A.K. Saxena, Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors, SAR QSAR Environ. Res. 21 (2010), pp. 445-462.
7. N.M. Shah, M.P. Patel, and R.G. Patel, New N-arylamino biquinoline derivatives: Synthesis, antimicrobial, antituberculosis, and antimalarial evaluation, Eur. J. Med. Chem. 54 (2012), pp. 239-247.
8. S.P. Prajapati, N.K. Kaushik, M. Zaveri, D. Mohanakrishanan, N. Kawathekar, and D. Sahal, Synthesis, characterization and antimalarial evaluation of new b-benzoylstyrene derivatives of acridine, Arabian J. Chem. (2012), pp. 1-7.
9. A.K. Gupta, S.S. Bhunia, V.M. Balaramnavar, and A.K. Saxena, Pharmacophore modelling, molecular docking and virtual screening for EGFR (HER 1) tyrosine kinase inhibitors, SAR QSAR Environ. Res. 22 (2011), pp. 239-263.
10. A.K. Gupta, and A.K. Saxena, 3D-QSAR CoMFA and CoMSIA studies on a set of diverse-adrenergic receptor antagonists, Med. Chem. Res. 20 (2011), pp. 1455-1464.
11. J. Sridhara, M. Foroozesha, and C.L.K. Stevens, A QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR, SAR QSAR Environ. Res. 22 (2011), pp. 681-697.
12. M. Tukulula, S. Little, J. Gut, P.J. Rosenthal, B. Wan, S.G. Franzblau, and K. Chibale, The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivatives, Eur. J. Med. Chem. 57 (2012), pp. 259-267.
13. SYBYL6.9, Tripos Inc., St. Louis, MO, USA.
14. B.L. Bush, R.B. and Nachbar, Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA, J. Comput. Aided Mol. Des. 7, (1993), 587-619.
15. V.N. Viswanadhan, A.K. Ghose, G.R. Revenkar, and R. Robins, Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics, J. Chem. Inf. Comput. Sci. 29 (1989), pp. 163-172.
16. R.D. Cramber III, D.E. Patterson, and J.D. Bunce, Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc. 110 (1988), pp. 5959-5967.
17. G. Klebe, U. Abraham, and T. Mietzner, Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity, J. Med. Chem. 37 (1994), pp. 4130-4146.
18. Y. Ai, S.T. Wang, P.H. Sun, and F.J. Song, Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as aurora a kinase inhibitors, Int. J. Mol. Sci. 12 (2011), pp. 1605-1624.
19. L. Ping, W.N. Chen, and W.M. Chen, Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches, Eur. J. Med. Chem. 46 (2011), pp. 77-94.
20. P. Prathipati and A.K. Saxena, Comparison of MLR, PLS and GA-MLR in QSAR analysis, SAR QSAR Environ. Res. 14 (2003), pp. 433-446.